MALIGNANT METASTATIC INSULINOMA TREATED WITH STREPTOZOTOCIN

A patient with metastatic insulinoma who suffered from severe hypoglycaemic attacks was treated with 7.5 of streptozotocin (Upjohn). Shortly after the start of treatment, the hypoglycaemic attacks ceased; fasting blood glucose levels and serum immunoreactive insulin values returned to normal upon completion of the treatment. Two years after treatment, the patient is well and active and has not had any attacks. The oral glucose tolerance test and tolbutamide stimulation test now show serum immunoreactive insulin excertion patterns similar to those seen in diabetics.

[1]  P. Schein.  Chemotherapeutic management of the hormone‐secreting endocrine malignancies , 1972, Cancer.

[2]  H. Lebovitz,et al.  The use of insulin dynamics in the evaluation of streptozotocin therapy of malignant insulinomas. , 1971, The Journal of clinical endocrinology and metabolism.

[3]  I. Murray-Lyon,et al.  Further studies on streptozotocin therapy for a multiple-hormone-producing islet cell carcinoma , 1971, Gut.

[4]  E. Nieschlag,et al.  THERAPIE EINES METASTASIERENDEN INSELZELLTUMORS MIT STREPTOZOTOCIN , 1971 .

[5]  R. Arky,et al.  Metastatic insulinoma treated with streptozotocin. , 1971, Annals of internal medicine.

[6]  T. T. Vogel.  Notes on streptozotocin in metastatic insulinoma , 1971, Journal of surgical oncology.

[7]  S. Taylor,et al.  Streptozotocin therapy for metastatic insulinoma. , 1970, Archives of internal medicine.

[8]  N. Mcintyre,et al.  Streptozotocin treatment of malignant islet cell tumour. , 1970, British medical journal.

[9]  W. Blackard,et al.  Effect of streptozotocin on qualitative aspects of plasma insulin in a patient with a malignant islet cell tumor. , 1970, The Journal of clinical endocrinology and metabolism.

[10]  L. Sadoff.  Effects of Streptozotocin in a Patient with Islet Cell Carcinoma , 1969, Diabetes.

[11]  P. Bastenie,et al.  Treatment of insulinoma with streptozotocin. , 1969, Lancet.

[12]  A. Eddleston,et al.  Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. , 1968, Lancet.

[13]  Y. Ogawa,et al.  Islet Cell Tumors of the Pancreas , 1968 .

[14]  D. Porte,et al.  Clinical Use of Diazoxide and Mechanism for Its Hyperglycemic Effects , 1966, Diabetes.

[15]  H. Blomquist.  Hyperinsulinism and islet cell tumor of the pancreas. , 1966, Annales chirurgiae et gynaecologiae Fenniae.

[16]  W. Longmire,et al.  Insulin Secreting Tumors of the Pancreas , 1964, Annals of surgery.

[17]  N. Rakieten,et al.  Studies on the diabetogenic action of streptozotocin (NSC-37917). , 1963, Cancer chemotherapy reports.

[18]  N. Rakieten.  Studies on the diabetogenic action of streptozotocin , 1963 .

[19]  L. B. Flinn,et al.  Alloxan in the treatment of a case of islet cell carcinoma of the pancreas with liver metastases. , 1947, Annals of internal medicine.

[20]  H. E. Robertson,et al.  CARCINOMA OF THE ISLANDS OF THE PANCREAS: HYPERINSULINISM AND HYPOGLYCEMIA , 1927 .